ArticleJournal of experimental & clinical cancer research : CR2019

Co-administration of 20(S)-protopanaxatriol (g-PPT) and EGFR-TKI overcomes EGFR-TKI resistance by decreasing SCD1 induced lipid accumulation in non-small cell lung cancer.

Quanfu Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.